JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Odagaki, Y.
Right arrow Articles by Koyama, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odagaki, Y.
Right arrow Articles by Koyama, T.

Vol. 291, Issue 3, 1250-1256, December 1999

Activation of G Proteins by Neuropeptide Y and gamma -Aminobutyric AcidB Receptor Agonists in Rat Cerebral Cortical Membranes through Distinct Modes of Action1

Yuji Odagaki, Nobuyuki Nishi, Shin Nakagawa and Tsukasa Koyama

Department of Psychiatry, Hokkaido University School of Medicine, Sapporo, Japan

The neuropeptide Y (NPY)-elicited increase in high-affinity GTPase activity in the rat cerebral cortical membranes was assayed and compared with the gamma -aminobutyric acid (GABA)B receptor-mediated response, representative of the conventional receptor-dependent mode of G protein activation. GABA and a selective GABAB receptor agonist, (±)-baclofen, stimulated the high-affinity GTPase activity in a concentration-dependent and saturable manner, with a strict Mg2+ dependence. On the other hand, NPY (10 µM)-stimulated high-affinity GTPase activity was detectable even in the absence of Mg2+. The concentration-response curve for NPY-induced increase in high-affinity GTPase activity in the presence of 2 mM MgCl2 revealed a biphasic pattern, and NPY (100 nM)-stimulated activity was dependent on MgCl2. In the presence of 2 mM MgCl2, the increase in high-affinity GTPase activity by 100 nM NPY was almost fully inhibited by a selective NPY Y-1 receptor antagonist, (R)-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]argininamide (BIBP3226), whereas the effect of 10 µM NPY was only partially antagonized by this compound. The increase in the activity by 10 µM NPY in the absence of MgCl2 was not at all inhibited by BIBP3226. The high-affinity GTPase activity was augmented by [Leu31,Pro34]NPY (porcine) but not by desamido-NPY, NPY(13-36) (porcine), or rat pancreatic polypeptide at submicromolar concentrations. These results indicate that NPY activates G proteins through two distinct modes of action: the conventional receptor-mediated pathway through NPY Y-1 receptor subtype dominant in the presence of the lower concentrations of NPY and receptor-independent, direct G protein activation driven by the higher concentrations of NPY.


0022-3565/99/2913-1250$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.